Pharmacologic and Nonpharmacologic Management of Atrial Fibrillation

Title

Pharmacologic and Nonpharmacologic Management of Atrial Fibrillation

Creator

Dahya Vishal; Taigen Tyler L

Publisher

Medical Clinics of North America

Date

2019
2019-09

Description

Atrial fibrillation (AF) is the most common arrhythmia and its management may be organized into risk stratification and/or treatment of heart failure, stroke prevention, and symptom control. At the core of symptom control, treatment is tailored to either allow AF continue with controlled heart rates, so-called rate control, versus restoring and maintaining sinus rhythm or rhythm control. Rate control strategies mainly use rate-modulating medications, whereas rhythm control treatment includes therapy aimed at restoring sinus rhythm, including pharmacologic and direct current cardioversion, as well as maintenance of sinus rhythm, including anti-arrhythmic medications and ablation therapy.

Subject

amiodarone; Antiarrhythmic drugs; antiarrhythmic-drugs; Atrial fibrillation; cardioversion; catheter ablation; Catheter ablation; dronedarone; efficacy; heart-failure; maintaining sinus rhythm; mortality; Pharmacologic management; therapy
October 2019 Update

Rights

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

Search for Full-text

Users with a NEOMED Library login can search for full-text journal articles at the following url: https://libraryguides.neomed.edu/home

Pages

835-+

Issue

5

Volume

103

NEOMED College

NEOMED College of Medicine

Citation

Dahya Vishal; Taigen Tyler L, “Pharmacologic and Nonpharmacologic Management of Atrial Fibrillation,” NEOMED Bibliography Database, accessed January 25, 2021, https://neomed.omeka.net/items/show/6560.

Social Bookmarking